Clinical TrailsOral Mosnodenvir Pill’s Rocky Road: 60% Dengue Success in Phase 2a Tr... Oral Mosnodenvir Pill’s Rocky Road: 60% Dengue Success in Phase 2a Tr... Read Post »
New Drug ApprovalChina’s First Domestic IL-23p19 Antibody PECONDLE Gains NMPA Approval... China’s First Domestic IL-23p19 Antibody PECONDLE Gains NMPA Approval... Read Post »
Clinical Trails Health TidingsAlexion Advances ALXN2420 to Phase 2: PeptiDream Unlocks Acromegaly Milesto... Alexion Advances ALXN2420 to Phase 2: PeptiDream Unlocks Acromegaly Milesto... Read Post »
New Drug ApprovalTreating ADHD Across Lifespan: Otsuka’s Centanafadine NDA Submission Insi... Treating ADHD Across Lifespan: Otsuka’s Centanafadine NDA Submission Insi... Read Post »
New Drug ApprovalEisai Completes Fast Track sBLA to FDA and Submits NDA to Japan PMDA for Su... Eisai Completes Fast Track sBLA to FDA and Submits NDA to Japan PMDA for Su... Read Post »
New Drug ApprovalFDA Accelerates Approval of Otsuka’s VOYXACT® (sibeprenlimab-szsi) for I... FDA Accelerates Approval of Otsuka’s VOYXACT® (sibeprenlimab-szsi) for I... Read Post »
Clinical Trails New Drug ApprovalNovo Nordisk Files FDA sNDA for Wegovy 7.2 mg Higher Dose After 20.7% Weigh... Novo Nordisk Files FDA sNDA for Wegovy 7.2 mg Higher Dose After 20.7% Weigh... Read Post »
New Drug ApprovalFDA Approves Imfinzi as First and Only Perioperative Immunotherapy for Earl... FDA Approves Imfinzi as First and Only Perioperative Immunotherapy for Earl... Read Post »
New Drug ApprovalSanofi and Regeneron’s Dupixent Wins EU Approval as First Targeted Therap... Sanofi and Regeneron’s Dupixent Wins EU Approval as First Targeted Therap... Read Post »
Drugs Safety Alert ResearchAbbott Initiates Medical Device Correction for Freestyle Libre 3 Sensors in... Abbott Initiates Medical Device Correction for Freestyle Libre 3 Sensors in... Read Post »
Clinical TrailsSarepta Receives FDA Approval to Begin ENDEAVOR Cohort 8 Investigating Enha... Sarepta Receives FDA Approval to Begin ENDEAVOR Cohort 8 Investigating Enha... Read Post »
New Drug ApprovalSerum Institute of India’s SIILTIBCY® Receives MHRA Authorization in... Serum Institute of India’s SIILTIBCY® Receives MHRA Authorization in... Read Post »
Clinical TrailsNovo Nordisk’s Amycretin Phase 2 Trial Shows Up to 14.5% Weight Loss and ... Novo Nordisk’s Amycretin Phase 2 Trial Shows Up to 14.5% Weight Loss and ... Read Post »
New Drug ApprovalFDA Approves Itvisma (Onasemnogene Abeparvovec-brve), the First Intrathecal... FDA Approves Itvisma (Onasemnogene Abeparvovec-brve), the First Intrathecal... Read Post »
Clinical TrailsJohnson & Johnson’s Posdinemab Fails to Meet Primary Endpoint in Auτ... Johnson & Johnson’s Posdinemab Fails to Meet Primary Endpoint in Auτ... Read Post »
Clinical TrailsKyowa Kirin Launches Phase 3 AOBA Study of KK8398 (Infigratinib) for Achond... Kyowa Kirin Launches Phase 3 AOBA Study of KK8398 (Infigratinib) for Achond... Read Post »
Clinical TrailsSarepta’s SRP-1003 siRNA Program Hits Key Enrollment Milestone, Triggers ... Sarepta’s SRP-1003 siRNA Program Hits Key Enrollment Milestone, Triggers ... Read Post »
Clinical TrailsNovo Nordisk’s Evoke Phase 3 Trial Fails to Show Semaglutide Benefit in A... Novo Nordisk’s Evoke Phase 3 Trial Fails to Show Semaglutide Benefit in A... Read Post »
Clinical TrailsNew Hope for Stroke Survivors: Bayer’s Asundexian Shows Promise in Reduci... New Hope for Stroke Survivors: Bayer’s Asundexian Shows Promise in Reduci... Read Post »
Drugs Safety Alert ResearchThe Truth about “Ozempic Penis”: What Men Should Know About Semaglutide... The Truth about “Ozempic Penis”: What Men Should Know About Semaglutide... Read Post »
Health Tidings ResearchEli Lilly Hits $1 Trillion Market Cap: How Mounjaro and Zepbound Revolution... Eli Lilly Hits $1 Trillion Market Cap: How Mounjaro and Zepbound Revolution... Read Post »
New Drug ApprovalKoselugo Approved by FDA for Adults with Neurofibromatosis Type 1: A New Tr... Koselugo Approved by FDA for Adults with Neurofibromatosis Type 1: A New Tr... Read Post »
New Drug ApprovalFDA Approves KEYTRUDA® (pembrolizumab) and KEYTRUDA QLEX™ with Padcev® ... FDA Approves KEYTRUDA® (pembrolizumab) and KEYTRUDA QLEX™ with Padcev® ... Read Post »
Drugs Safety Alert ResearchFDA Investigates Fatal Case of Neutralizing Antibodies to ADAMTS13 after Ad... FDA Investigates Fatal Case of Neutralizing Antibodies to ADAMTS13 after Ad... Read Post »
New Drug ApprovalFDA Grants Full Approval to AbbVie’s EPKINLY® (epcoritamab-bysp) Plu... FDA Grants Full Approval to AbbVie’s EPKINLY® (epcoritamab-bysp) Plu... Read Post »
Clinical TrailsPfizer’s Next-Gen mRNA Flu Shot: A New Standard in Vaccine Innovation Pfizer’s Next-Gen mRNA Flu Shot: A New Standard in Vaccine Innovation Read Post »
Clinical TrailsAgios’ Mitapivat Delivers Positive Hemoglobin Gains but Mixed Pain‑Cr... Agios’ Mitapivat Delivers Positive Hemoglobin Gains but Mixed Pain‑Cr... Read Post »
Clinical TrailsMerck Announces Positive Topline Results from Pivotal Phase 3 Trial of Dora... Merck Announces Positive Topline Results from Pivotal Phase 3 Trial of Dora... Read Post »
New Drug ApprovalFDA Clears Regeneron and Bayer’s EYLEA HD® for Macular Edema after R... FDA Clears Regeneron and Bayer’s EYLEA HD® for Macular Edema after R... Read Post »
Clinical TrailsNovo Nordisk’s Wegovy® (Semaglutide 2.4 mg) Delivers Liver Health Benefi... Novo Nordisk’s Wegovy® (Semaglutide 2.4 mg) Delivers Liver Health Benefi... Read Post »
Clinical TrailsLibrexia ACS Trial Ends Early as Efficacy Endpoint Not Met, BMS and J&J... Librexia ACS Trial Ends Early as Efficacy Endpoint Not Met, BMS and J&J... Read Post »
New Drug ApprovalFDA Approves Redemplo (Plozasiran) to Lower Triglycerides in Adults with Fa... FDA Approves Redemplo (Plozasiran) to Lower Triglycerides in Adults with Fa... Read Post »
Clinical TrailsWINREVAIR Shows Promising Phase 2 Results in CpcPH with HFpEF WINREVAIR Shows Promising Phase 2 Results in CpcPH with HFpEF Read Post »
Policy & AcquisitionsJohnson & Johnson Acquires Halda Therapeutics and Its RIPTAC Platform Johnson & Johnson Acquires Halda Therapeutics and Its RIPTAC Platform Read Post »
New Drug ApprovalEMA CHMP November 2025: Ten New Medicines Recommended for Approval EMA CHMP November 2025: Ten New Medicines Recommended for Approval Read Post »
New Drug ApprovalSandoz Launches Tyruko® in US, First Biosimilar to Biogen’s Tysabri, Enh... Sandoz Launches Tyruko® in US, First Biosimilar to Biogen’s Tysabri, Enh... Read Post »
Clinical TrailsJohnson & Johnson’s TREMFYA® Confirms Unique Joint Protection in Pso... Johnson & Johnson’s TREMFYA® Confirms Unique Joint Protection in Pso... Read Post »
Clinical TrailsHow AUSTEDO and AUSTEDO XR Improve Quality of Life in Tardive Dyskinesia Pa... How AUSTEDO and AUSTEDO XR Improve Quality of Life in Tardive Dyskinesia Pa... Read Post »
Clinical TrailsVir Biotechnology’s Tobevibart & Elebsiran Combo Achieves Breakth... Vir Biotechnology’s Tobevibart & Elebsiran Combo Achieves Breakth... Read Post »
Drugs Safety Alert ResearchSarepta’s ELEVIDYS Updated FDA Labeling: New Boxed Warning and Narrow... Sarepta’s ELEVIDYS Updated FDA Labeling: New Boxed Warning and Narrow... Read Post »
Lifestyle ResearchHow Quitting Tobacco Adds Years to HIV and Tuberculosis Patients’ Lives How Quitting Tobacco Adds Years to HIV and Tuberculosis Patients’ Lives Read Post »
Clinical TrailsVertex Shows Promising Phase 1/2 Data for Povetacicept in IgA Nephropathy a... Vertex Shows Promising Phase 1/2 Data for Povetacicept in IgA Nephropathy a... Read Post »
Clinical TrailsGilead’s Investigational Single-Tablet Regimen of Bictegravir and Lenacap... Gilead’s Investigational Single-Tablet Regimen of Bictegravir and Lenacap... Read Post »
Policy & AcquisitionsPfizer Finalizes up to $10B Acquisition of Metsera after Fierce Bidding War... Pfizer Finalizes up to $10B Acquisition of Metsera after Fierce Bidding War... Read Post »
Health TidingsFDA Approves CAPLYTA® (Lumateperone) as Adjunctive Therapy for Major Depre... FDA Approves CAPLYTA® (Lumateperone) as Adjunctive Therapy for Major Depre... Read Post »
Clinical TrailsRegeneron Factor XI Antibodies Show Superior Efficacy for VTE Prevention... Regeneron Factor XI Antibodies Show Superior Efficacy for VTE Prevention... Read Post »
Clinical TrailsAmgen’s Repatha® Slashes First Major Cardiovascular Events Risk by 25% i... Amgen’s Repatha® Slashes First Major Cardiovascular Events Risk by 25% i... Read Post »
Clinical TrailsLivdelzi® (Seladelpar) Achieves New Milestone in PBC: Phase 3 Data Show La... Livdelzi® (Seladelpar) Achieves New Milestone in PBC: Phase 3 Data Show La... Read Post »
Clinical TrailsGanaplacide’s Innovative Discovery from 2.3 Million Molecules Yields ... Ganaplacide’s Innovative Discovery from 2.3 Million Molecules Yields ... Read Post »
Clinical TrailsAstraZeneca Baxdrostat Shows Breakthrough 14 mmHg 24-Hour Blood Pressure Re... AstraZeneca Baxdrostat Shows Breakthrough 14 mmHg 24-Hour Blood Pressure Re... Read Post »
